Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-04-20

FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)

View source ↗

Summary

The FDA approved a supplemental application for tretinoin from Padagis US LLC, authorizing changes to the labeling under the ANDA for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRETINOIN (TRETINOIN)

Snippet

SUPPL AP for TRETINOIN (TRETINOIN)